Advertisement

Acta Diabetologica

, Volume 52, Issue 5, pp 937–942 | Cite as

Clinical factors that predict remission of diabetes after different bariatric surgical procedures: interdisciplinary group of bariatric surgery of Verona (G.I.C.O.V.)

  • Maria Grazia ZentiEmail author
  • Ilaria Rubbo
  • Giulia Ceradini
  • Elisabetta Rinaldi
  • Luisa Nadalini
  • Marco Battistoni
  • Michele Genna
  • Enzo Bonora
  • Giacomo Zoppini
Original Article

Abstract

Aims

The aims of the study were to investigate weight loss and glycemic control parameters after different bariatric surgical procedures in type 2 diabetes (T2D) obese patients and identify patients’ factors that predict diabetes remission.

Methods

The study included 105 obese T2D patients (66 women and 39 men) who underwent laparoscopic gastric banding (LAGB, 11 subjects, age 47 ± 10 years, BMI 42.3 ± 8.3 kg/m2), or laparoscopic Roux-en-Y gastric bypass (RYBP, 77 subjects, age 50 ± 8 years, BMI 45.7 ± 6.8 kg/m2), or sleeve gastrectomy (SG, 17 subjects, age 49 ± 11 years, BMI 50.2 ± 8.8 kg/m2) during 2005–2012 period.

Results

The average percentage of weight loss at 12 months after surgery was 26.4 ± 9.8 %, and it was maintained at 24 and 36 months of follow-up. Diabetes remission occurred in 68.6 % of study participants (4/11 of LAGB, 54/77 of RYBP and 14/17 of SG). In multivariate Cox analysis, age, duration of diabetes, surgical procedure and glycated hemoglobin <53 mmol/mol (7 %) resulted significant predictors of diabetes remission (age RR = 0.97, 95 %CI 0.94–1.0, p = 0.05; diabetes duration RR = 0.93, 95 % CI 0.86–0.99, p = 0.036; rif LAGB, RYBP RR = 3.9, 95 % CI 1.31–11.57, p = 0.014; SG RR = 5.6, 95 % CI 1.67–18.64, p = 0.005; glycated hemoglobin RR = 0.54, 95 % CI 0.32–0.92, p = 0.024).

Conclusions

Bariatric surgical procedures that modify the upper gastrointestinal tract anatomy (RYBP and SG) are more successful in producing weight loss and remission of T2D than those that simply restrict stomach capacity (LAGB). Younger age, short duration of diabetes and better glucose control confer higher probability of achieving remission of diabetes.

Keywords

Diabetes remission Diabetes Bariatric surgery Obesity Observational study 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

The study has been reviewed by the Ethic Committee of the University of Verona, and has been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki.

Informed consent

Informed consent was obtained from all patients for being included in the study.

References

  1. 1.
    Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ (2013) Bariatric surgery versus non surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMJ 347:f5934PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Sjöström L, Lindroos AK, Peltonen M, Torgerson J et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693CrossRefPubMedGoogle Scholar
  3. 3.
    Sjöström L, Peltonen M, Jacobson P et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65CrossRefPubMedGoogle Scholar
  4. 4.
    Sjöström L, Narbro K, Sjöström CD, Karaso K, Larsson B, Wedel H et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752CrossRefPubMedGoogle Scholar
  5. 5.
    Bonora E (2006) The metabolic syndrome and cardiovascular disease. Ann Med 38:64–80CrossRefPubMedGoogle Scholar
  6. 6.
    Colagiuri S (2010) Diabesity: therapeutic options. Diabetes Obes Metab 12:463–473CrossRefPubMedGoogle Scholar
  7. 7.
    Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323PubMedGoogle Scholar
  8. 8.
    Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwa JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:1567–1576PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–1585CrossRefPubMedGoogle Scholar
  10. 10.
    Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP (2013) Roux-en-Y gastric bypass versus intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA 309:2240–2249PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X (2013) Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 101:50–56CrossRefPubMedGoogle Scholar
  12. 12.
    Brethauer SA, Aminian A, Romer-Talamas H et al (2013) Can diabetes be surgically cured? Ann Surg 258:628–637PubMedCentralPubMedGoogle Scholar
  13. 13.
    Adams ST, Salhab M, Hussain ZI, Miller GV, Leveson SH (2013) Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of the literature. Acta Diabetol 50:475–478CrossRefPubMedGoogle Scholar
  14. 14.
    Moghissi ES, Korytkowski MT, DiNardo M et al (2009) American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:1119–1131PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Kim D, Kim KJ, Huh JH, Lee BW, Kang ES, Cha BS, Lee HC (2012) The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function. Clin Endocrinol 77:679–683CrossRefGoogle Scholar
  17. 17.
    Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19CrossRefPubMedGoogle Scholar
  18. 18.
    Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256CrossRefPubMedGoogle Scholar
  19. 19.
    Pok EH, Lee WJ (2014) Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World J Gastroenterol 20:14315–14328PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Wang GF, Yan YX, Xu N, Yin D, Hui Y, Zhang JP, Han GJ, Ma N, Wu Y, Xu JZ, Yang T (2015) Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg 25:199–208PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Li C, Yang H, Tong G, Shen S, Feng W, Bi Y, Zhu D (2014) Correlations between A1c, fasting glucose, 2 h postload glucose, and βcell function in the Chinese population. Acta Diabetol 51:601–608CrossRefPubMedGoogle Scholar
  22. 22.
    Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, Hamamoto Y, Hosokawa M, Seino Y, Inagaki N (2008) Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract 82:353–358CrossRefPubMedGoogle Scholar
  23. 23.
    Campos GM, Rabl C, Roll GR, Peeva S, Prado Kris, Smith J, Vittinghoff E (2011) Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass versus banding results of a two-cohort pair-matched study. Arch Surg 146:149–155CrossRefPubMedGoogle Scholar
  24. 24.
    Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH (2014) Long-term follow-up after bariatric surgery. Syst Rev JAMA 312:934–942CrossRefGoogle Scholar
  25. 25.
    Pham S, Gancel A, Scotte M, Houivet E, Huet E, Lefebvre H, Khun JM, Prevost G (2014) Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study. J Obes. doi: 10.1155/2014/638203 Epub 2014 MayPubMedCentralPubMedGoogle Scholar
  26. 26.
    Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass and adjustable gastric banding on type 2 diabetes. Surg Endosc 24:1005–1010CrossRefPubMedGoogle Scholar
  27. 27.
    Erqou S, Lee CC, Adler AI (2014) Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. Diabetologia 57:2444–2452CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2015

Authors and Affiliations

  • Maria Grazia Zenti
    • 1
    Email author
  • Ilaria Rubbo
    • 1
  • Giulia Ceradini
    • 1
  • Elisabetta Rinaldi
    • 1
  • Luisa Nadalini
    • 2
  • Marco Battistoni
    • 3
  • Michele Genna
    • 3
  • Enzo Bonora
    • 1
  • Giacomo Zoppini
    • 1
  1. 1.Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, UOC EndocrinologiaUniversity and University Hospital of VeronaVeronaItaly
  2. 2.USD Clinical Psychology, Department of MedicineUniversity Hospital of VeronaVeronaItaly
  3. 3.Division of Bariatric Surgery, Department of SurgeryUniversity Hospital of VeronaVeronaItaly

Personalised recommendations